Genertec Universal Medical (2666) Announces Board Update and Committee Structures

Bulletin Express11-17

On 17 November 2025, Genertec Universal Medical Group Company Limited (2666) released an announcement detailing its Board composition and the directors’ roles. The Board includes Executive Directors, Non-executive Directors, and Independent Non-executive Directors. The Executive Directors are the Chairman, Mr. Chen Shisu, the Chief Executive Officer, Mr. Wang Wenbing, and Ms. Wang Lin. The Non-executive Directors comprise Mr. Tong Chaoyin, Mr. Lin Chunhai, and Mr. Huang Youjie. The Independent Non-executive Directors are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Xu Zhiming, and Mr. Chan, Hiu Fung Nicholas.

Five committees report to the Board. The Audit Committee is chaired by Mr. Li, with Mr. Chow and Mr. Tong as members. The Remuneration Committee is chaired by Mr. Chow, alongside Mr. Lin, Mr. Huang, Mr. Li, and Mr. Xu. Leading the Nomination Committee is Mr. Chen, supported by Ms. Wang Lin, Mr. Li, Mr. Chow, and Mr. Chan. The Strategy and ESG Committee is chaired by Mr. Chen, with Mr. Huang serving as a member. The Risk Control Committee comprises Mr. Wang and Mr. Tong.

The announcement was issued in Beijing, the People’s Republic of China, on 17 November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment